Published in PLoS One on July 06, 2012
Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy. J Am Soc Nephrol (2014) 1.11
Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy. J Nephropathol (2013) 1.11
Eculizumab treatment for rescue of renal function in IgA nephropathy. Pediatr Nephrol (2014) 1.09
Current Understanding of the Role of Complement in IgA Nephropathy. J Am Soc Nephrol (2015) 0.99
Biomarkers in IgA nephropathy: relationship to pathogenetic hits. Expert Opin Med Diagn (2013) 0.96
Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment. PLoS One (2014) 0.84
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy. Front Immunol (2016) 0.83
FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy. PLoS One (2013) 0.79
C4d deposits in IgA nephropathy: where does complement activation come from? Pediatr Nephrol (2017) 0.78
Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy. PLoS One (2016) 0.77
Decreased Serum C3 Levels in Immunoglobulin A (IgA) Nephropathy with Chronic Kidney Disease: A Propensity Score Matching Study. Med Sci Monit (2017) 0.75
Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis. Sci Rep (2017) 0.75
Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects. World J Nephrol (2016) 0.75
Implication of urinary complement factor H in the progression of immunoglobulin A nephropathy. PLoS One (2015) 0.75
Primary glomerulonephritis: A review of important recent discoveries. Kidney Res Clin Pract (2013) 0.75
Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy. Kidney Int (2017) 0.75
Increased C4 and decreased C3 levels are associated with a poor prognosis in patients with immunoglobulin A nephropathy: a retrospective study. BMC Nephrol (2017) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45
The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med (1987) 3.99
Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol (2004) 2.48
The pathophysiology of IgA nephropathy. J Am Soc Nephrol (2011) 2.27
Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol (1997) 2.12
Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol (2008) 1.76
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol (2006) 1.72
Relationship between serum IgA/C3 ratio and progression of IgA nephropathy. Intern Med (2004) 1.61
Prognostic indicators of IgA nephropathy in the Chinese--clinical and pathological perspectives. Nephrol Dial Transplant (2002) 1.57
A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol (2011) 1.51
A tricontinental view of IgA nephropathy. Nephrol Dial Transplant (2003) 1.46
IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract (2011) 1.41
Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol (2010) 1.39
Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol (1987) 1.38
Mesangial C4d deposition: a new prognostic factor in IgA nephropathy. Nephrol Dial Transplant (2008) 1.33
IgA nephropathy: recent developments. J Am Soc Nephrol (2000) 1.31
Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant (1998) 1.31
Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol (2006) 1.28
Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol (2012) 1.21
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Activated complement C3: a potentially novel predictor of progressive IgA nephropathy. Kidney Int (1997) 1.11
Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obes (Lond) (2007) 1.03
Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients. Semin Nephrol (1987) 1.02
Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy. Kidney Int (2006) 1.01
Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int (1986) 0.98
Complement activation in IgA nephropathy. Kidney Int (1987) 0.98
Pathological predictors of prognosis in immunoglobulin A nephropathy: a review. Curr Opin Nephrol Hypertens (2009) 0.96
The role of secretory IgA and complement in IgA nephropathy. Semin Nephrol (2008) 0.95
Significance of glomerular deposition of C3c and C3d in IgA nephropathy. Am J Nephrol (2000) 0.93
Levels of lectin pathway proteins in plasma and synovial fluid of rheumatoid arthritis and osteoarthritis. Rheumatol Int (2011) 0.91
An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies. Clin Exp Immunol (1993) 0.89
Exploring complement activation to develop biomarkers for systemic lupus erythematosus. Arthritis Rheum (2004) 0.89
An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy. Nephrol Dial Transplant (2004) 0.87
Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal (2000) 0.87
Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure. Clin Exp Nephrol (2004) 0.86
Activation of the acute phase response and complement C3 in patients with IgA nephropathy. Am J Kidney Dis (2000) 0.86
Histopathology of lupus nephritis. Clin Rev Allergy Immunol (2011) 0.84
Metabolic impact on serum levels of complement component 3 in Japanese patients. J Clin Lab Anal (2010) 0.83
Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease? Ann Gen Psychiatry (2011) 0.83
Significance of broad distribution of electron-dense deposits in patients with IgA nephropathy. Med Mol Morphol (2012) 0.82
Plasma levels of complement factors 3 and 4, orosomucoid and opsonic functions in anorexia nervosa. Acta Paediatr Scand (1979) 0.81
Low serum complement levels in anorexia nervosa. Am J Dis Child (1989) 0.80
Factors indicating renal injury in pediatric bilateral ureteropelvic-junction obstruction. Urology (2013) 2.60
Preassembled zinc-finger arrays for rapid construction of ZFNs. Nat Methods (2011) 2.54
Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int (2004) 2.13
Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int (2007) 1.83
Circulating α-klotho levels in CKD and relationship to progression. Am J Kidney Dis (2013) 1.76
Risk factors for adverse outcomes after peritonitis-related technique failure. Perit Dial Int (2008) 1.54
Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant (2009) 1.53
Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients. Nephrol Dial Transplant (2009) 1.50
Points to be considered when applying FibroScan S probe in children with biliary atresia. J Pediatr Gastroenterol Nutr (2014) 1.48
Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behçet's disease. J Invest Dermatol (2011) 1.46
Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One (2013) 1.37
Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy. Nephrol Dial Transplant (2011) 1.34
The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int (2008) 1.34
Red blood cell distribution width is an independent predictor of mortality in patients with gram-negative bacteremia. Shock (2012) 1.34
Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea. Yonsei Med J (2005) 1.32
Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension (2013) 1.32
Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats. Am J Physiol Renal Physiol (2009) 1.25
Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol (2012) 1.21
Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis. Tohoku J Exp Med (2011) 1.20
Friction anisotropy-driven domain imaging on exfoliated monolayer graphene. Science (2011) 1.19
Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant (2007) 1.19
Corticotropin-releasing hormone downregulates IL-10 production by adaptive forkhead box protein 3-negative regulatory T cells in patients with atopic dermatitis. J Allergy Clin Immunol (2011) 1.18
Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis (2011) 1.16
High-performance ambipolar diketopyrrolopyrrole-thieno[3,2-b]thiophene copolymer field-effect transistors with balanced hole and electron mobilities. Adv Mater (2011) 1.15
An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Crit Care (2013) 1.14
Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant (2009) 1.11
Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. J Biol Chem (2012) 1.09
Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol (2004) 1.08
Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol (2002) 1.07
Early referral to a nephrologist improved patient survival: prospective cohort study for end-stage renal disease in Korea. PLoS One (2013) 1.06
Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.05
Long-term clinical outcomes of peritoneal dialysis patients: single center experience from Korea. Perit Dial Int (2008) 1.05
A novel protein phosphatase indirectly regulates phytochrome-interacting factor 3 via phytochrome. Biochem J (2008) 1.05
KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. BMC Nephrol (2014) 1.04
Nutcracker syndrome combined with IgA nephropathy in a child with recurrent hematuria. Pediatr Int (2006) 1.04
Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab (2012) 1.04
Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid (2013) 1.03
PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility. J Mol Cell Cardiol (2008) 1.03
Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. Metabolism (2010) 1.03
Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Diabetes Res Clin Pract (2011) 1.03
Role of the plastidic glucose translocator in the export of starch degradation products from the chloroplasts in Arabidopsis thaliana. New Phytol (2010) 1.02
Differential expression of nephrin according to glomerular size in early diabetic kidney disease. J Am Soc Nephrol (2007) 1.02